Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FT1U2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,645
Award facts
- Contract value 100% obligated
- $3,645.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for supplying pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with the parent IDC valued at $499.999 billion through December 31, 2036. The company's extensive product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, enabling it to fulfill the diverse pharmaceutical requirements of military healthcare operations globally. The PPV-G GEN V contract structure provides the Defense Logistics Agency with the flexibility to issue multiple firm fixed-price delivery orders for recurring medical supply needs, with this Mirena systems award representing one component of DMS Pharmaceutical Group's broader pharmaceutical supply responsibilities to the Department of Defense.
Quick answers
Who was awarded contract SPE2DB26FT1U2?
SPE2DB26FT1U2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FT1U2 worth?
The government has obligated $3,645 on SPE2DB26FT1U2.
Is contract SPE2DB26FT1U2 an order under another contract?
Yes. SPE2DB26FT1U2 is a delivery order under SPE2DB20D9371, an indefinite delivery contract.
Was contract SPE2DB26FT1U2 competed?
The extent of competition for SPE2DB26FT1U2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award